Continuing Education

The CSTE Annual Conference is a gathering of public health professionals and practitioners focused on epidemiology and informatics.  Each year the conference content is determined by the abstracts submitted.

The educational purpose of the CSTE Annual Conference is to offer professionals and practitioners the opportunity to enhance their knowledge, improve their surveillance and epidemiology skills, and exchange information on best practices and strategies in applied epidemiology.

Learning Objectives

  • Identify at least 3 best practices in applied epidemiology.
  • Describe at least 3 best practices for surveillance and epidemiology.
  • Discuss at least 2 public health practice skills presented in workshops.
  • Identify at least 2 strategies OR tools to improve public health practice
  • Articulate the importance of interprofessional collaboration for applied epidemiology.

Types of Continuing Education

CSTE has partnered with CDC to provide continuing education for conference attendees.  Eligible sessions include the NASPHV business meeting, Sunday workshops, and plenaries. CSTE anticipates offering up to 20 hours of continuing education for:


  • Doctors
  • Nurses
  • Health Educators
  • Veterinarians
  • Certified in Public Health
  • General Practitioners

Instructions for Obtaining Continuing Education

– In order to receive continuing education (CE) for CM4543, 2022 CSTE Annual Conference, please visit TCEO and follow these 9 Simple Steps before July 26, 2022.

– The course access code is CSTEconference2022.

– Register for the 2022 CSTE Annual Conference. Attend eligible sessions including workshops, and plenaries. Complete the Evaluation at

FEES: Paid conference registration is required to receive CE. No additional fees are necessary to be eligible for CE.


In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners and presenters wish to disclose they have no financial relationship(s) with ineligible companies with the exception of with the exception of:

  • Dr. Scott Commins and he wishes to disclose that he is receiving up-to-date topic author royalties and is with the Speaker’s Bureau with Genentech (omalizumab).
  • Dr. Adrienne Simmons and she wishes to disclose that she serves as an advisor on the Gilead Sciences Hepatitis Delta Advisory Board. The honorarium was provided to her organization, the Hepatitis Education Project. The Hepatitis Education Project is a nonprofit that receives funding from a diversity of sources, including pharmaceutical companies, insurance companies, governments, foundations and private donations.
  • Dr. Megan Ranney and she wishes to disclose that she a one-time honorarium for panel discussion on digital health. The honorarium was provided to her by the Massachusetts College of Pharmacy and Health Sciences.

All of the relevant financial relationships listed for these individuals have been mitigated.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of:

  • Chris Fredregill’s discussion on Racing to Stay Ahead of Vector-Borne Diseases. He will be discussing Wolbachia and its use against mosquitoes with MosquitoMate

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.


For additional questions regarding continuing education, please contact
Jessica Arrazola at [email protected]